Chinese listed companies ramp up virus efforts after president’s call

Chinese listed companies ramp up virus efforts after president’s call
FILE PHOTO: A passenger wears a mask at Shanghai railway station in Shanghai, China January 22, 2020. REUTERS/Aly Song SHANGHAI (Reuters) – A number of Chinese listed companies – ranging from biotech firms, drugmakers, mask producers and thermometer manufacturers – announced efforts in response to a national call to fight the outbreak of the Wuhan coronavirus. The new, flu-like virus,... Read More

Samsung sets up anti-corruption panel as chief faces trials

Samsung sets up anti-corruption panel as chief faces trials
SEOUL (Reuters) – South Korea’s Samsung Group, whose leader faces trials over a bribery scandal involving former president Park Geun-hye, has appointed external experts to a new oversight panel to stamp out criminal conduct, the chief of the committee said on Thursday. FILE PHOTO: Samsung Electronics Vice Chairman, Jay Y. Lee, arrives at Seoul high court in Seoul, South Korea,... Read More

Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million

Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million
TOKYO (Reuters) – Astellas Pharma Inc (4503.T) has bought U.S.-based Xyphos Biosciences Inc to expand its immuno-oncology business, a deal worth up to $665 million including potential development milestones and its second acquisition announced this month. Astellas Pharma’s logo is pictured at its headquarters in Tokyo, Japan, December 3, 2019. REUTERS/Kim Kyung-Hoon Japan’s second biggest drugmaker by sales paid $120... Read More

Factbox: What’s in the U.S.-China ‘phase one’ trade deal

Factbox: What’s in the U.S.-China ‘phase one’ trade deal
WASHINGTON (Reuters) – The United States and China have agreed on the terms of a “phase one” trade deal that reduces some U.S. tariffs on Chinese goods while boosting Chinese purchases of American farm, energy and manufactured goods and addressing some U.S. complaints about intellectual property practices. Following are details of the deal released by both sides. The broad... Read More

Shares of SoftBank-backed OneConnect rise 5% in U.S. market debut

Shares of SoftBank-backed OneConnect rise 5% in U.S. market debut
(Reuters) – Shares of OneConnect Financial Technology jumped 5% in their U.S. market debut on Friday, valuing the Chinese cloud tech firm at $3.79 billion. FILE PHOTO: SoftBank Corp. placard is prepared during a ceremony to mark the company’s debut on the Tokyo Stock Exchange in Tokyo, Japan December 19, 2018. REUTERS/Issei Kato Shares opened at $10.51 compared with its... Read More

Factbox: Labor, environment, drugs top changes to North American trade deal

Factbox: Labor, environment, drugs top changes to North American trade deal
MEXICO CITY (Reuters) – Stronger worker and environmental protections top changes to a new version of the North American trade deal signed by U.S., Mexican and Canadian officials on Tuesday that clears the way for a long-delayed vote in the U.S. Congress. FILE PHOTO: Canadian Deputy Prime Minister Chrystia Freeland gestures as she speaks during a meeting at the Presidential... Read More

France’s Sanofi to buy biotech firm Synthorx for $2.5 billion

France’s Sanofi to buy biotech firm Synthorx for $2.5 billion
PARIS (Reuters) – Sanofi (SASY.PA) said on Monday it had agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion aimed at beefing up the French drugmaker’s pipeline of drugs for cancer and auto-immune disorders. FILE PHOTO: The logo of Sanofi is seen at the company’s research and production centre in Vitry-sur-Seine, France, August 6,... Read More

Pfizer, Novartis lead $2 billion spending spree on gene therapy production

Pfizer, Novartis lead $2 billion spending spree on gene therapy production
(Reuters) – Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world’s priciest medicines. FILE PHOTO: A logo for Pfizer is displayed on a monitor on the floor at the New York Stock... Read More

Pfizer, Novartis lead pharma spending spree on gene therapy production

Pfizer, Novartis lead pharma spending spree on gene therapy production
(Reuters) – Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world’s priciest medicines. FILE PHOTO: A logo for Pfizer is displayed on a monitor on the floor at the New York Stock... Read More

H&M-backed startup puts bacteria to work in green dyeing process

H&M-backed startup puts bacteria to work in green dyeing process
STOCKHOLM/NORWICH, Britain (Reuters) – A British biotech startup is developing a method of textile dyeing that taps into the bright colors of birds and butterflies and has micro-organisms recreate them on fabric, slashing the use of water and heavy chemicals in the process. Patchwork of different types of material dyed using bacteria in a lab at biotech firm Colorifix in... Read More